{"id":3583,"date":"2022-03-09T08:16:55","date_gmt":"2022-03-09T07:16:55","guid":{"rendered":"https:\/\/www.cvs-avocats.com\/prevost-laboratory-concept-optimise-structure-financement\/"},"modified":"2025-03-03T16:44:39","modified_gmt":"2025-03-03T15:44:39","slug":"prevost-laboratory-concept-optimise-structure-financement","status":"publish","type":"post","link":"https:\/\/www.cvs-avocats.com\/fr\/prevost-laboratory-concept-optimise-structure-financement\/","title":{"rendered":"Pr\u00e9vost Laboratory Concept optimise sa structure de financement"},"content":{"rendered":"<div class=\"section__body\">\n<div class=\"block-strong-text\">\n<h3>Moins de deux ans apr\u00e8s l\u2019entr\u00e9e au capital d\u2019Ab\u00e9nex comme actionnaire majoritaire, Pr\u00e9vost Laboratory Concept, soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e dans la conception et la fabrication de produits cosm\u00e9tiques et de compl\u00e9ments alimentaires, met en place un refinancement.<\/h3>\n<\/div>\n<article class=\"article-normal\">\n<div class=\"article__entry\">\n<p>\u00ab Ce refinancement intervient dans un contexte de surperformance du laboratoire qui g\u00e9n\u00e8re des r\u00e9sultats bien au-del\u00e0 des pr\u00e9visions d\u2019origine. La soci\u00e9t\u00e9 s\u2019est structur\u00e9e autour d\u2019une \u00e9quipe de direction anim\u00e9e par Marc-Henry Lussigny ce qui lui permet d\u2019\u00eatre un acteur de r\u00e9f\u00e9rence sur le march\u00e9 des produits cosm\u00e9tiques \u00bb, pr\u00e9cise Paul Bertrand, associ\u00e9 chez Ab\u00e9nex.<\/p>\n<\/div>\n<\/article>\n<ul class=\"list-icons\">\n<li><a href=\"https:\/\/www.finyear.com\/Prevost-Laboratory-Concept-optimise-sa-structure-de-financement_a46967.html\">Retrouvez l&rsquo;article de Finyear<\/a><\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Moins de deux ans apr\u00e8s l\u2019entr\u00e9e au capital d\u2019Ab\u00e9nex comme actionnaire majoritaire, Pr\u00e9vost Laboratory Concept, soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e dans la conception et la fabrication de produits cosm\u00e9tiques et de compl\u00e9ments alimentaires, met en place un refinancement. \u00ab Ce refinancement intervient dans un contexte de surperformance du laboratoire qui g\u00e9n\u00e8re des r\u00e9sultats bien au-del\u00e0 des pr\u00e9visions d\u2019origine. [&hellip;]<\/p>\n","protected":false},"author":18,"featured_media":3584,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-3583","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/posts\/3583","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/comments?post=3583"}],"version-history":[{"count":0,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/posts\/3583\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/media\/3584"}],"wp:attachment":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/media?parent=3583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/categories?post=3583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/tags?post=3583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}